Anand S Lagoo

Summary

Affiliation: Duke University Medical Center
Country: USA

Publications

  1. doi request reprint Morphologic features of 115 lymphomas of the orbit and ocular adnexa categorized according to the World Health Organization classification: are marginal zone lymphomas in the orbit mucosa-associated lymphoid tissue-type lymphomas?
    Anand S Lagoo
    Department of Pathology, Duke University Medical Center, Durham, NC 27710, USA
    Arch Pathol Lab Med 132:1405-16. 2008
  2. ncbi request reprint Morphologic examination of sequential bone marrow biopsies after nonmyeloablative stem cell transplantation complements molecular studies of donor engraftment
    Anand S Lagoo
    Department of Pathology, Duke University Medical Center, Durham, NC 27710, USA
    Arch Pathol Lab Med 130:1479-88. 2006
  3. ncbi request reprint The value of fluorescence in situ hybridization and polymerase chain reaction in the diagnosis of B-cell non-Hodgkin lymphoma by fine-needle aspiration
    Anne M Safley
    Department of Pathology, Duke University Medical Center, Durham, NC 27710, USA
    Arch Pathol Lab Med 128:1395-403. 2004
  4. ncbi request reprint Posttransplant lymphoproliferative disorder following nonmyeloablative allogeneic stem cell transplantation
    Matthew J Snyder
    Department of Pathology, Duke University Medical Center, Durham, NC 27710, USA
    Am J Surg Pathol 28:794-800. 2004
  5. pmc Feasibility of low-dose interleukin-2 therapy following T-cell-depleted nonmyeloablative allogeneic hematopoietic stem cell transplantation from HLA-matched or -mismatched family member donors
    David A Rizzieri
    Department of Medicine, Division of Cellular Therapy, Duke University Medical Center, Durham, North Carolina 27710, USA
    Cancer Invest 29:56-61. 2011
  6. doi request reprint A single tube, four-color flow cytometry assay for evaluation of ZAP-70 and CD38 expression in chronic lymphocytic leukemia
    Nagwa M Hassanein
    Department of Pathology, Box 3712, Duke University Medical Center, Durham, NC 27710, USA
    Am J Clin Pathol 133:708-17. 2010
  7. pmc Deep sequencing of the small RNA transcriptome of normal and malignant human B cells identifies hundreds of novel microRNAs
    Dereje D Jima
    Duke Institute for Genome Sciences and Policy, Duke University, Durham, NC, USA
    Blood 116:e118-27. 2010
  8. ncbi request reprint Clinicopathologic findings in high-grade B-cell lymphomas with typical Burkitt morphologic features but lacking the MYC translocation
    Deborah W Sevilla
    Department of Pathology, Duke University Medical Center, Durham, NC 27710, USA
    Am J Clin Pathol 128:981-91. 2007
  9. pmc The genetic landscape of mutations in Burkitt lymphoma
    Cassandra Love
    Duke Institute for Genome Sciences and Policy, Duke University, Durham, NC, USA
    Nat Genet 44:1321-5. 2012
  10. ncbi request reprint Posttransplant lymphoproliferative disorder after umbilical cord blood transplantation in children
    Jerald Z Gong
    Department of Pathology, Duke University Medical Center, Durham, NC 27710, USA
    Am J Surg Pathol 30:328-36. 2006

Collaborators

Detail Information

Publications23

  1. doi request reprint Morphologic features of 115 lymphomas of the orbit and ocular adnexa categorized according to the World Health Organization classification: are marginal zone lymphomas in the orbit mucosa-associated lymphoid tissue-type lymphomas?
    Anand S Lagoo
    Department of Pathology, Duke University Medical Center, Durham, NC 27710, USA
    Arch Pathol Lab Med 132:1405-16. 2008
    ..Marginal zone lymphomas (MZLs) are the most common lymphomas encountered in the orbit and ocular adnexa. The accurate categorization of these lymphomas is critical to avoid undertreatment or overtreatment...
  2. ncbi request reprint Morphologic examination of sequential bone marrow biopsies after nonmyeloablative stem cell transplantation complements molecular studies of donor engraftment
    Anand S Lagoo
    Department of Pathology, Duke University Medical Center, Durham, NC 27710, USA
    Arch Pathol Lab Med 130:1479-88. 2006
    ..Nonmyeloablative stem cell transplantation (NMSCT) is a mode of immunotherapy increasingly employed in treating hematologic, lymphoid, and solid tumors. Patients are monitored principally by molecular analysis of donor engraftment...
  3. ncbi request reprint The value of fluorescence in situ hybridization and polymerase chain reaction in the diagnosis of B-cell non-Hodgkin lymphoma by fine-needle aspiration
    Anne M Safley
    Department of Pathology, Duke University Medical Center, Durham, NC 27710, USA
    Arch Pathol Lab Med 128:1395-403. 2004
    ..Molecular genetic analyses have been predicted to improve the diagnostic accuracy of fine-needle aspiration of B-cell non-Hodgkin lymphoma...
  4. ncbi request reprint Posttransplant lymphoproliferative disorder following nonmyeloablative allogeneic stem cell transplantation
    Matthew J Snyder
    Department of Pathology, Duke University Medical Center, Durham, NC 27710, USA
    Am J Surg Pathol 28:794-800. 2004
    ..All three PTLDs arose 6 to 7 months after NMST and were rapidly fatal. The pathology of the PTLD in all cases was donor origin, EBV positive, diffuse large B-cell lymphoma...
  5. pmc Feasibility of low-dose interleukin-2 therapy following T-cell-depleted nonmyeloablative allogeneic hematopoietic stem cell transplantation from HLA-matched or -mismatched family member donors
    David A Rizzieri
    Department of Medicine, Division of Cellular Therapy, Duke University Medical Center, Durham, North Carolina 27710, USA
    Cancer Invest 29:56-61. 2011
    ..The primary objective of this pilot study was to evaluate the feasibility of administering IL-2 following a T-cell-depleted nonmyeloablative hematopoietic stem cell transplant...
  6. doi request reprint A single tube, four-color flow cytometry assay for evaluation of ZAP-70 and CD38 expression in chronic lymphocytic leukemia
    Nagwa M Hassanein
    Department of Pathology, Box 3712, Duke University Medical Center, Durham, NC 27710, USA
    Am J Clin Pathol 133:708-17. 2010
    ..It may be necessary to evaluate several prognostic markers simultaneously in CLL, and availability of convenient assays for ZAP-70 and CD38 is desirable for optimal clinical decision making...
  7. pmc Deep sequencing of the small RNA transcriptome of normal and malignant human B cells identifies hundreds of novel microRNAs
    Dereje D Jima
    Duke Institute for Genome Sciences and Policy, Duke University, Durham, NC, USA
    Blood 116:e118-27. 2010
    ..Thus, our work suggests that more than a third of the miRNAs present in most cellular types are currently unknown and that these miRNAs may regulate important cellular functions...
  8. ncbi request reprint Clinicopathologic findings in high-grade B-cell lymphomas with typical Burkitt morphologic features but lacking the MYC translocation
    Deborah W Sevilla
    Department of Pathology, Duke University Medical Center, Durham, NC 27710, USA
    Am J Clin Pathol 128:981-91. 2007
    ..Provisional identification of MYC- lymphomas with typical Burkitt morphologic features as an entity separate from DLBCL will facilitate further studies and possible categorization as a separate entity...
  9. pmc The genetic landscape of mutations in Burkitt lymphoma
    Cassandra Love
    Duke Institute for Genome Sciences and Policy, Duke University, Durham, NC, USA
    Nat Genet 44:1321-5. 2012
    ..We show experimentally that ID3 mutations promote cell cycle progression and proliferation. Our work thus elucidates commonly occurring gene-coding mutations in Burkitt lymphoma and implicates ID3 as a new tumor suppressor gene...
  10. ncbi request reprint Posttransplant lymphoproliferative disorder after umbilical cord blood transplantation in children
    Jerald Z Gong
    Department of Pathology, Duke University Medical Center, Durham, NC 27710, USA
    Am J Surg Pathol 30:328-36. 2006
    ..PTLD may be of donor or recipient origin depending on engraftment status. Both monomorphic and polymorphic histology may be seen, and monomorphic histology appears to predict an unfavorable prognosis...
  11. pmc Re-induction therapy decisions based on day 14 bone marrow biopsy in acute myeloid leukemia
    Tod A Morris
    Division of Medical Oncology, Duke University Health System, Durham, NC, USA
    Leuk Res 37:28-31. 2013
    ..The aim of our review was to evaluate the accuracy of a day 14 BM biopsy in determining the need for re-induction chemotherapy...
  12. pmc A role for E2F activities in determining the fate of Myc-induced lymphomagenesis
    Rachel E Rempel
    Duke Institute for Genome Sciences and Policy, Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, North Carolina, United States of America
    PLoS Genet 5:e1000640. 2009
    ....
  13. pmc Genetic heterogeneity of diffuse large B-cell lymphoma
    Jenny Zhang
    Duke Institute for Genome Sciences and Policy, Duke University, Durham, NC 27710, USA
    Proc Natl Acad Sci U S A 110:1398-403. 2013
    ..Thus, our study reveals the tremendous genetic heterogeneity that underlies lymphomas and highlights the need for personalized medicine approaches to treating these patients...
  14. ncbi request reprint Diagnostic impact of core-needle biopsy on fine-needle aspiration of non-Hodgkin lymphoma
    Jerald Z Gong
    Department of Pathology, Duke University Medical Center, Durham, North Carolina 27710, USA
    Diagn Cytopathol 31:23-30. 2004
    ..Cases insufficient for diagnosis may be seen in both core-needle biopsy and FNA. A combined approach reduces the number of insufficient cases and is recommended in routine FNA practice...
  15. pmc Patterns of microRNA expression characterize stages of human B-cell differentiation
    Jenny Zhang
    Duke Institute for Genome Sciences and Policy, Duke University, Durham, NC 27710, USA
    Blood 113:4586-94. 2009
    ..Thus, our data demonstrate that microRNAs may be important in maintaining the mature B-cell phenotype in normal and malignant B cells...
  16. doi request reprint Diagnostic and clinical considerations in concomitant bone marrow involvement by plasma cell myeloma and chronic lymphocytic leukemia/monoclonal B-cell lymphocytosis: a series of 15 cases and review of literature
    Christopher L Alley
    Department of Pathology, Duke University Medical Center, Durham, North Carolina 27710, USA
    Arch Pathol Lab Med 137:503-17. 2013
    ..Plasma cell myeloma and chronic lymphocytic leukemia are both common hematologic malignancies, sharing many epidemiologic features. Concomitant detection of the 2 conditions poses special diagnostic challenges for the pathologist...
  17. ncbi request reprint Lymphoma of the female genital tract: current status
    Anand S Lagoo
    Department of Pathology, Duke University Medical Center, Durham, NC 27110, USA
    Int J Gynecol Pathol 25:1-21. 2006
    ..Finally, the possible etiology of these conditions is discussed in light of the emerging paradigm of mucosa-associated lymphoid tissue lymphomas...
  18. ncbi request reprint Burkitt lymphoma arising in organ transplant recipients: a clinicopathologic study of five cases
    Jerald Z Gong
    Department of Pathology, Duke University Medical Center, Durham, NC 27710, USA
    Am J Surg Pathol 27:818-27. 2003
    ..Genotypic and phenotypic aberrations are often present. Rituximab may be an effective alternative to conventional combination chemotherapy in the treatment of a posttransplant Burkitt lymphoma...
  19. doi request reprint Lymph node infarction: role of underlying malignancy, tumour proliferation fraction and vascular compromise--a study of 35 cases and a comprehensive review of the literature
    Xiaoyin sara Jiang
    Department of Pathology, Duke University Medical Center, Durham, NC 27710, USA
    Histopathology 62:315-25. 2013
    ..To determine the roles of the presence of malignancy, tumour proliferation fraction, vascular compromise and therapeutic and diagnostic manipulations in lymph node infarction (LNI)...
  20. doi request reprint Distinct expression patterns of CD123 and CD34 on normal bone marrow B-cell precursors ("hematogones") and B lymphoblastic leukemia blasts
    Nagwa M Hassanein
    Department of Pathology, Duke University Medical Center, Durham, NC 22170, USA
    Am J Clin Pathol 132:573-80. 2009
    ....
  21. pmc Utilization of pathway signatures to reveal distinct types of B lymphoma in the Emicro-myc model and human diffuse large B-cell lymphoma
    Seiichi Mori
    Department of Molecular Genetics and Microbiology, Duke Institute for Genome Sciences and Policy, Duke University Medical Center, Durham, North Carolina 27708, USA
    Cancer Res 68:8525-34. 2008
    ..Taken together, these studies provide insight into the complexity of the oncogenic process and a novel strategy for dissecting the heterogeneity of B lymphoma...
  22. pmc SMAD4 is required for development of maximal endotoxin tolerance
    Hongjie Pan
    Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA
    J Immunol 184:5502-9. 2010
    ..We conclude that in THP-1 cells and primary murine cells, SMAD4 signaling is required for maximal induction of endotoxin tolerance via modulation of SHIP1 and IRAK-M...
  23. ncbi request reprint Nodular lymphocyte predominant Hodgkin lymphoma at atypical locations may be associated with increased numbers of large cells and a diffuse histologic component
    David T Yang
    Department of Pathology, University of Utah Health Sciences Center, Salt Lake City, Utah 84132, USA
    Am J Hematol 83:218-21. 2008
    ..From 55 cases of NLPHL, we describe a possible subset of NLPHL occurring in older individuals at atypical sites, associated with increased numbers of large cells, a diffuse histologic component, and expression of Bcl-2...